Gail Walkinshaw

1.9k total citations
30 papers, 1.5k citations indexed

About

Gail Walkinshaw is a scholar working on Cancer Research, Molecular Biology and Neurology. According to data from OpenAlex, Gail Walkinshaw has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cancer Research, 12 papers in Molecular Biology and 7 papers in Neurology. Recurrent topics in Gail Walkinshaw's work include Cancer, Hypoxia, and Metabolism (22 papers), High Altitude and Hypoxia (6 papers) and Mitochondrial Function and Pathology (5 papers). Gail Walkinshaw is often cited by papers focused on Cancer, Hypoxia, and Metabolism (22 papers), High Altitude and Hypoxia (6 papers) and Mitochondrial Function and Pathology (5 papers). Gail Walkinshaw collaborates with scholars based in United States, Germany and Finland. Gail Walkinshaw's co-authors include Catherine Waters, Lee A. Flippin, Ian Mitchell, Peppi Koivunen, Johanna Myllyharju, Bianca Nowlan, Jean-Pierre Lévesque, Ingrid G. Winkler, Catherine E. Forristal and Valérie Barbier and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Gail Walkinshaw

30 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gail Walkinshaw United States 19 566 428 334 232 217 30 1.5k
Takuma Mabuchi Japan 17 753 1.3× 214 0.5× 491 1.5× 278 1.2× 214 1.0× 23 2.3k
Ambreena Siddiq United States 11 686 1.2× 376 0.9× 167 0.5× 114 0.5× 152 0.7× 12 1.1k
Jean-Christophe Copin United States 11 624 1.1× 301 0.7× 156 0.5× 218 0.9× 134 0.6× 11 1.3k
Woo Jean Kim South Korea 29 1.0k 1.8× 320 0.7× 262 0.8× 148 0.6× 218 1.0× 55 2.5k
Benoit D. Roussel France 23 660 1.2× 360 0.8× 210 0.6× 197 0.8× 330 1.5× 36 1.8k
Xiaohua Zhang China 22 756 1.3× 440 1.0× 131 0.4× 182 0.8× 105 0.5× 77 1.6k
Yang Tang China 25 1.2k 2.1× 499 1.2× 204 0.6× 164 0.7× 182 0.8× 57 2.2k
Frank Striggow Germany 24 1.0k 1.8× 161 0.4× 591 1.8× 196 0.8× 217 1.0× 36 1.8k
Noriaki Mitsuda Japan 19 1.0k 1.8× 226 0.5× 432 1.3× 122 0.5× 382 1.8× 50 1.8k
Oliver Herrmann Germany 17 510 0.9× 281 0.7× 156 0.5× 120 0.5× 128 0.6× 29 1.3k

Countries citing papers authored by Gail Walkinshaw

Since Specialization
Citations

This map shows the geographic impact of Gail Walkinshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail Walkinshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail Walkinshaw more than expected).

Fields of papers citing papers by Gail Walkinshaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gail Walkinshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail Walkinshaw. The network helps show where Gail Walkinshaw may publish in the future.

Co-authorship network of co-authors of Gail Walkinshaw

This figure shows the co-authorship network connecting the top 25 collaborators of Gail Walkinshaw. A scholar is included among the top collaborators of Gail Walkinshaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gail Walkinshaw. Gail Walkinshaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bagadia, Prachi, Verónica M. Rodríguez, Mark D. Sternlicht, et al.. (2023). 1333 FG-3165 is a novel galectin-9 neutralizing antibody that inhibits galectin-9-mediated dimerization of TIM-3 and galectin-9-induced apoptosis of CD4+ and CD8+ T cells. SHILAP Revista de lepidopterología. A1484–A1484. 1 indexed citations
2.
Dimova, Elitsa Y., Joni M. Mäki, Anu Laitala, et al.. (2022). Contribution of HIF-P4H isoenzyme inhibition to metabolism indicates major beneficial effects being conveyed by HIF-P4H-2 antagonism. Journal of Biological Chemistry. 298(8). 102222–102222. 4 indexed citations
3.
Balzo, Ughetta del, Pierre Signore, Gail Walkinshaw, et al.. (2020). Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease. Journal of Pharmacology and Experimental Therapeutics. 374(2). 342–353. 47 indexed citations
4.
Mäkelä, Kari A., Karl‐Heinz Herzig, Franziska Dengler, et al.. (2020). HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD. Journal of Molecular Medicine. 98(5). 719–731. 17 indexed citations
5.
Kietzmann, Thomas, Gail Walkinshaw, Daniela Mennerich, et al.. (2019). Systemic inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 in mice protects from alcohol-induced fatty liver disease. Redox Biology. 22. 101145–101145. 22 indexed citations
6.
Bisht, Kavita, Marion E. G. Brunck, Taichi Matsumoto, et al.. (2019). HIF prolyl hydroxylase inhibitor FG-4497 enhances mouse hematopoietic stem cell mobilization via VEGFR2/KDR. Blood Advances. 3(3). 406–418. 12 indexed citations
7.
Nowlan, Bianca, Kathryn Futrega, Marion E. G. Brunck, et al.. (2017). HIF-1α-stabilizing agent FG-4497 rescues human CD34+ cell mobilization in response to G-CSF in immunodeficient mice. Experimental Hematology. 52. 50–55.e6. 8 indexed citations
8.
Dimova, Elitsa Y., Sohvi Hörkkö, Helena Gylling, et al.. (2016). Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 36(4). 608–617. 75 indexed citations
9.
Forristal, Catherine E., Bianca Nowlan, Rebecca Jacobsen, et al.. (2015). HIF-1α is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1α. Leukemia. 29(6). 1366–1378. 43 indexed citations
10.
Khamaisi, Mogher, Jonathan H. Axelrod, Christian Rosenberger, et al.. (2014). Endothelin-converting enzyme is a plausible target gene for hypoxia-inducible factor. Kidney International. 87(4). 761–770. 19 indexed citations
11.
12.
Hörkkö, Sohvi, Roberto Blanco Sequeiros, Eveliina Lammentausta, et al.. (2014). HIF Prolyl 4-Hydroxylase-2 Inhibition Improves Glucose and Lipid Metabolism and Protects Against Obesity and Metabolic Dysfunction. Diabetes. 63(10). 3324–3333. 100 indexed citations
13.
Reischl, Stefan, Lexiao Li, Gail Walkinshaw, et al.. (2014). Inhibition of HIF prolyl-4-hydroxylases by FG-4497 Reduces Brain Tissue Injury and Edema Formation during Ischemic Stroke. PLoS ONE. 9(1). e84767–e84767. 84 indexed citations
14.
Keränen, Mikko, Raimo Tuuminen, S. Syrjälä, et al.. (2013). Differential Effects of Pharmacological HIF Preconditioning of Donors Versus Recipients in Rat Cardiac Allografts. American Journal of Transplantation. 13(3). 600–610. 15 indexed citations
15.
Forristal, Catherine E., Bianca Nowlan, Valérie Barbier, et al.. (2012). FG-4497, a Pharmacological Stabilizer of HIF-1α Protein, Synergistically Enhances Hematopoietic Stem Cells (HSC) Mobilization in Response to G-CSF and Plerixafor. Blood. 120(21). 216–216. 3 indexed citations
16.
Laitala, Anu, Gail Walkinshaw, Joni M. Mäki, et al.. (2012). Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis. Blood. 120(16). 3336–3344. 50 indexed citations
17.
Milošević, Javorina, Anatol Manaenko, Sigrid C. Schwarz, et al.. (2009). Non-hypoxic Stabilization of Hypoxia-Inducible Factor Alpha (HIF-α): Relevance in Neural Progenitor/Stem Cells. Neurotoxicity Research. 15(4). 367–380. 64 indexed citations
18.
Schneider, Christina, Stephan Sylvest Keller, Gail Walkinshaw, et al.. (2009). Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain. Brain Research. 1280. 43–51. 16 indexed citations
19.
Bamford, Mark J., et al.. (2000). Therapeutic Applications of Apoptosis Research. Experimental Cell Research. 256(1). 1–11. 34 indexed citations
20.
Walkinshaw, Gail & Catherine Waters. (1995). Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease.. Journal of Clinical Investigation. 95(6). 2458–2464. 204 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takuma Mabuchi Breakdown of academic impact, for papers by Ambreena Siddiq Breakdown of academic impact, for papers by Jean-Christophe Copin Breakdown of academic impact, for papers by Woo Jean Kim Breakdown of academic impact, for papers by Benoit D. Roussel Breakdown of academic impact, for papers by Xiaohua Zhang Breakdown of academic impact, for papers by Yang Tang Breakdown of academic impact, for papers by Frank Striggow Breakdown of academic impact, for papers by Noriaki Mitsuda Breakdown of academic impact, for papers by Oliver Herrmann
Rankless by CCL
2026